CNS Pharmaceuticals announces 1-for-12 reverse stock split

CNS Pharmaceuticals (CNSP) announced a 1-for-12 reverse split of its common stock. Beginning on July 22, 2025, the Company’s common stock will continue to trade on The Nasdaq Capital Market on a split adjusted basis under the trading symbol “CNSP” but will trade under the following new CUSIP number: 18978H508.